Vimarsana
Biggest News Aggregation in the World

Page 13 - Pfizer Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Ventures Today - Breaking & Trending Today

Eli Lilly Bets Nearly $500M on Metabolic Disease Pact with Nimbus - Vimarsana News

Eli Lilly Bets Nearly $500M on Metabolic Disease Pact with Nimbus

Nimbus Therapeutics scored a $496 million payday through a collaboration and licensing deal with pharma giant Eli Lilly for potential therapeutics for metabolic diseases

ImmunOs Therapeutics Announces Appointment of Joseph - Vimarsana News

ImmunOs Therapeutics Announces Appointment of Joseph

- Seasoned immuno-oncology executive brings significant medical and biopharma expertise Schlieren (Zurich Area), Switzerland, and Gaithersburg, MD,...

Capstan Therapeutics launches to deliver on in vivo cell engineering - Vimarsana News

Capstan Therapeutics launches to deliver on in vivo cell engineering

Capstan Therapeutics has launched to combine cell therapy and genetic medicines to bring safer medicines to patients in multiple indications.

Nimbus Therapeutics Closes $125M Private Financing to Advance Clinical Programs in Autoimmune Diseases and Oncology - Vimarsana News

Nimbus Therapeutics Closes $125M Private Financing to Advance Clinical Programs in Autoimmune Diseases and Oncology

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Fierce Biotech names STORM Therapeutics as one of its Fierce 15 Biotech Companies of 2022 - Vimarsana News

Fierce Biotech names STORM Therapeutics as one of its Fierce 15 Biotech Companies of 2022

STORM recognised as an innovative early-stage biotechnology company pioneering novel drug targets CAMBRIDGE, England, Sept. 12, 2022 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the